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Abstract: Newborn mice are unable to clear Pneumocystis (PC) infection with the same efficiency as 
adults due, in part, to their inability to develop a robust immune response to infection until three 
weeks of age. It is known that infants tend develop a Th2 skewed response to antigen so we sought 
to determine whether a biased cytokine response altered the clearance of PC infection in neonatal 
mice. P. murina infection in neonatal mice resulted in increased IL-4 expression by CD4 T cells and 
myeloid cells, augmented IL-13 secretion within the airways and increased arginase activity in the 
airways, indicative of Th2-type responses. P. murina-infected IL-4Rα−/− neonates had a shift towards 
Th1 cytokine production and increased numbers of CD4 and CD8 T cells within the lung as well as 
elevated levels of P. murina-specific IgG. IFNγ−/− and IL-23 p19−/− mice had altered CD4-T cell-de-
pendent cytokine and cell responses. Though we could alter the T helper cell environment in neo-
natal knockout mice, there was no loss in the ability of these pups to clear infection. It is possible 
that the Th2 phenotype normally seen in neonatal mice protects the developing lung from pro-in-
flammatory immune responses without compromising host defense against P. murina. 
Keywords neonate; lung; infection; mice; Pneumocystis 
 
1. Introduction 
PC is an opportunistic fungal pathogen that is the causative agent of Pneumocystis 
Pneumonia (PCP) in immunocompromised hosts. Primarily known as an AIDS-defining 
illness, PCP outbreaks were first described among malnourished children within orphan 
homes [1,2]. An early primary exposure to PC is evident within the population, as a large 
portion of children 2–3 years of age has been found to make antibody specific to PC anti-
gens [3–7]. Healthy infants are susceptible to PC carriage, likely because of ongoing post-
natal lung development and immaturity of the immune system [6–8]. We have shown in 
mouse models that neonates fail to mount an immune response to PC comparable to that 
seen in adults [9,10] likely due to an inexperienced adaptive immune system as well as an 
inherent inability to develop a robust innate immune response to the infection [11,12]. 
Clearance of PC requires a functional CD4 T cell response coupled with activation 
and response of B cells and macrophages [13–17]. We previously demonstrated in a mu-
rine infection model that mice are unable to mount an immune response to PC until 3 
weeks of age, resulting in delayed resolution of infection as compared to adults [9,10,18–
23]. This corresponds to delayed T cell infiltration into airways, delayed macrophage in-
filtration and activation, and delayed cytokine production [9,10,19,21,22]. T cells isolated 
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from draining lymph nodes of pups, however, are capable of producing IFNγ and prolif-
erating in response to anti-CD3 stimulation [18], thereby suggesting that deficiencies in 
the neonatal immune response to PC also reside within innate immune defenses. Neonatal 
alveolar macrophages (AMs), in fact, do display intrinsic defects, as they are unable to 
translocate NFκB (p65) in response to in vitro stimulation with PC [23]. Augmented levels 
of TGFβ within the developing neonatal lung [23] may affect the way in which AMs are 
able to respond to PC within the lung. 
T cells from neonates have been shown to respond to various stimuli with a bias to-
ward T helper 2 cytokines in the absence of strong co-stimulation [24–27]. Th1, Th2, Th17 
and Treg responses have all been described during infection to PC [28–34]. Moreover, in 
the absence of IFNγ, IL-4, or IL-17 mice are able to clear P. murina organisms, albeit with 
an altered kinetics in some instances [32,35–37]. Because the T cell induced cytokine envi-
ronment drives macrophage activation, it is likely that a heterogeneous macrophage pop-
ulation also exists in the immune response to infection. AMs from healthy humans and 
mice have been described to have an alternative-like phenotype due to constitutive ex-
pression of mannose receptor (MR) and Ym1 [38]. IL-4 and IL-13 mediated activation of 
AMs drives increased expression of these markers and induction of arginase activity. Be-
cause AMs are among the first cells to encounter pathogens within the lungs, an alterna-
tive-like phenotype may allow these cells to initially respond to infectious agents without 
inducing an unnecessary pro-inflammatory response. Data from Nelson et al. demon-
strates that alternatively activated macrophages promote clearance of PC in a mouse 
model of infection [28,39]. We hypothesized that in response to P. murina neonatal mice 
would produce Th2 cytokines leading to alternative activation of AMs that facilitate clear-
ance of the organisms. We indeed found that CD4+ T cells produce IL-4 in response to P. 
murina as do a subpopulation of macrophages. IL-4 drove increased arginase activity in 
the lungs, indicative of alternatively activated macrophages but in the absence of IL-4 and 
arginase, there was no difference in the ability of infant mice to clear infection. However, 
IL-4Rα-deficient neonates unable to respond to either IL-4 or IL-13 had increased numbers 
of activated T cells in the lungs, reduced alternative activation of macrophages, and were 
able to clear P. murina with a slightly faster kinetics than wild type pups. Neonates defi-
cient in IFNγ or IL-23p19 were able to clear P. murina with a similar kinetics as wild type 
mice. These data suggested that a cytokine biased environment significantly effects T cell 
and macrophage activation and function in response to P. murina but has little effect on 
clearance of organisms. 
2. Materials and Methods 
2.1. Mice  
Eight-week-old BALB/c, C57BL/6, B6D2F1, C.129-Il4tm1Lky/J (4get), BALB/c-Il4ratm1Sz/J 
(IL-4Rα−/−), B6.129P2-Il4tm1Cgn/J (IL-4−/−), B6.129P2-Lyzstm1(cre)Ifo/J (LyzM-Cre), and C57BL/6-
Arg1tm1Pmu/J(Argfl/fl) mice were purchased from Taconic (Germantown, NY, USA) or Jack-
son Laboratories (Bar Harbor, ME, USA). Interferon γ knockout mice crossed with the 
Thy1.1/luciferase expressing (originally from Dr. Robert Negrin, Stanford University) 
(Thy1.1+IFNγ−/−) and Thy1.1+ C57Bl/6 mice were obtained from Dr. Sarah D’Orazio, Uni-
versity of Kentucky [40]. IL-23p19−/− mice (originally from Dr. Daniel Cua, Sherring-
Plough/DNAX Corp., San Francisco, CA, USA) were obtained from Dr. John S. Thompson 
(Lexington, KY, USA, Veterans Administration Medical Center (VAMC)) [41]. Mice were 
maintained and bred at the Veterinary Medical Unit of the VAMC or the University of 
Kentucky Department of Laboratory Animal Resources (DLAR) under specific pathogen-
free conditions. C.129S6(B6)-Rag2tm1FwaN12 (Rag−/−) from Taconic (Georgetown, NY, USA), 
used to maintain a P. murina source colony, were bred and maintained at the VAMC or 
DLAR in microisolator cages with sterile food and water. Use of animals was approved 
by the Institutional Animal Care and Use Committees at the University of Kentucky (pro-
tocol number: 2010-0692) and Lexington VAMC (protocol number: 2010 09-0010V). 
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2.2. Generation of LyzM-Cre x Argfl/fl Mice and Genotyping 
LyzM-Cre mice were bred to Argfl/fl mice to generate transgenic mice in which ar-
ginase was exclusively deleted from cells specific to the myeloid lineage. Tail snips were 
performed and DNA was isolated from mice to determine genotype by PCR. 
Arginase locus primers: 5′-TgC gAg TTC ATg ACT AAg gTT-3′; 5′-AAA gCT Cag 
gTg AAT Cgg-3′ (IDT, Coralville, IA, USA). Arginase PCR protocol: 94 °C for 3 min; 35 
cycles of: 94 °C for 30 s, 60 °C for 1 min, 72 °C for 1 min; 72 °C for 2 min. PCR products 
were run on a 3% Tris/Borate/EDTA (TBE) agarose gel and visualized under UV light. The 
presence of a 250 bp band indicated a mutant locus, 250 bp and 200 bp bands indicated a 
heterozygote locus, and a 200 bp band indicated a wildtype locus.  
LyzCre locus primers: 5′-CCC AgA AAT gCC AgA TTA Cg-3′; 5′-CTT ggg CTg CCA 
gAA TTT CTC-3′; 5′-TTA CAg TCg gCC Agg CTg AC-3′ (IDT). LyzCre PCR protocol: 94 
°C for 3 min; 35 cycles of 94 °C for 30 s, 62 °C for 1 min, 72 °C for 1 min; 72 °C for 2 min. 
PCR products were run on a 1.5% TBE agarose gel and visualized under UV light. The 
presence of a 700 bp band indicated a mutant locus, 700 bp and 350 bp bands indicated a 
heterozygote locus, and a 350 bp band indicated a wildtype locus. 
Mice containing mutant loci for LyzM-Cre and Argfl/fl were considered to have ar-
ginase deleted specifically from myeloid cells and will be referred to herein as Lyz-Arg−/− 
mice. Arginase activity assays on the lungs of these mice confirmed these results as did 
PCR on AMs isolated from the bronchial alveolar lavage fluid of the crossed mice.  
2.3. P. murina Isolation and Infection  
Lungs were excised from P. murina-infected Rag−/− mice and pushed through stainless 
steel mesh in Hank’s buffered saline solution (HBSS). Cell debris was removed by centrif-
ugation at 100× g for 3 min. P. murina organisms were enumerated by microscopy as pre-
viously described [9]. For inoculation with P. murina, mice were anesthetized with isoflu-
rane anesthesia. Eight-week-old adults and 24 to 72 h old neonates were inoculated in-
tranasally (i.n.) with 5 × 105 organisms per gram body weight resuspended in 50 µL or 10 
µL of HBSS, respectively. 
2.4. Isolation of Cells from Alveolar Spaces, Lungs, and Lymph Nodes  
Lung airways were lavaged with 5 exchanges of cold HBSS containing 3 mM EDTA. 
Bronchial alveolar lavage fluid (BALF) from the first wash was saved for quantitative cy-
tokine analysis. Left lung lobes were snap frozen in liquid nitrogen and stored at −80 °C 
for quantitative cytokine analysis or arginase assay. Right lung lobes were excised, 
minced, and digested in RPMI 1640 containing 3% heat-inactivated FCS, 1mg/mL colla-
genase A (MilliporeSigma, St. Louis, MO, USA), and 50 U/mL DNase (MilliporeSigma) 
for 1 h at 37 °C in an atmosphere of 5% CO2. Digested lungs were homogenized through 
70 µm nylon mesh screens to obtain single cell suspensions, and aliquots were taken for 
enumeration of P. murina. Tracheobronchial lymph nodes (TBLN) were excised and 
pushed through 70 µm nylon mesh screens in HBSS. Erythrocytes were lysed using a hy-
potonic solution. Cells were washed and counted. 
2.5. Enumeration of P. murina  
Aliquots of homogenized lungs were diluted, and 100 µL aliquots were spun onto 
glass slides. Slides were fixed in methanol and stained with Diff-Quik (Siemens 
Healthcare Diagnostics). P. murina nuclei were enumerated by microscopy as previously 
described [13], and lung burden was expressed as log10 nuclei/right lung lobe. 
2.6. Flow Cytometric Analysis  
For surface staining, lung lavage, lung digest, and TBLN cells were washed with PBS 
containing 0.1% BSA and 0.02% NaN3 (PBA), and 5 × 105 to 1 × 106 cells were subsequently 
stained with appropriate concentrations of fluorochrome conjugated antibodies against 
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murine T cell markers (CD4, CD8, CD44, CD62L) or macrophage markers (CD11c and 
CD11b). = Antibodies were purchased from BD Biosciences (Mt. View, CA, USA), Life 
Technologies, (Waltham, MA, USA), or BioRad (Hercules, CA, USA).  
For detection of intracellular Ym1 (STEMCELL Technologies, Vancouver, Canada), 
lung lavage and lung digest cells were stained for surface expression of CD11c and CD11b, 
as described above. Following surface staining, cells were fixed with 10% formalin for 20 
min and permeabilized with PBA containing 0.5% saponin. Non-specific binding sites 
were blocked using an antibody against CD16/CD32 (Life Technologies). Cells were incu-
bated with unconjugated anti-Ym1, followed by incubation with an allophycocyanin 
(APC)-conjugated anti-rabbit IgG (Jackson ImmunoResearch Laboratories, Inc., West 
Grove, PA, USA). Rabbit IgG was used as an isotype control (Jackson ImmunoResearch). 
For detection of IL-4-eGFP in 4get mice, lung lavage, lung digest, and TBLN cells 
were stimulated for 2 h with 50 ng/mL PMA and 1µg/mL ionomycin at 37 °C under an 
atmosphere of 5% CO2, with 10 µg/mL Brefeldin A being added for the last hour of incu-
bation to inhibit cytokine secretion. Cells were stained for surface expression of CD4, 
CD11c, or CD11b. Expression of cell surface and intracellular markers was determined by 
multiparameter flow cytometry using a FACSCalibur cytofluorometer (BD Biosciences) 
or a LSR II (BD Biosciences). Ten to fifty thousand events were routinely acquired for all 
analyses. Data were analyzed using FlowJo analysis software (BD BioSciences). Gating 
was done for lymphocytes or large cells using forward and side scatter.  
2.7. Cell Sorting  
Lung lavage cells obtained from infected 4get adult and neonatal mice were washed 
with PBA. For detection of IL-4-eGFP, cells were stimulated for 2 h with 50 ng/mL PMA 
and 1µg/mL ionomycin at 37 °C under an atmosphere of 5% CO2. Brefeldin A (10 µg/mL) 
was added for the last hour of incubation to inhibit cytokine secretion. Cells were stained 
for surface expression of CD11b and subsequently sorted based on positive expression of 
IL-4 and high, mid, or low expression of CD11b. Aliquots of sorted cells were spun onto 
glass slides, methanol fixed, and stained with DiffQuik. Differential counts were per-
formed by microscopy to enumerate cell types in each population collected. Images were 
obtained using a Spot digital camera attached to an Eclipse microscope (Nikon Melville, 
NY, USA). 
2.8. Cytokine Analysis  
Analysis of cytokines was performed on BALF. TNFα, IFNγ, IL-4, IL-5, and IL-13 
concentrations in the BALF were determined by Cytokine Bead Assay (CBA) per the man-
ufacturer’s specifications (BD Biosciences) or ELISA (Life Technologies). Samples ana-
lyzed by ELISA were read at a wavelength of 450 nm using a µQuant spectrophotometer 
equipped with KC Junior Software (Bio-Tek instruments, Inc., Winooski, VT, USA). The 
CBA was analyzed using a FACS Calibur cytofluorometer (BD Biosciences). Data were 
analyzed using BD FCAP Array software (BD Biosciences). 
2.9. Analysis of Arginase Production  
Lung digest cells (1 × 106 to 2 × 106) were resuspended in 100 µL or 200 µL of T-PER 
lysis buffer (Thermo Fisher, Waltham, MA, USA) containing 10% protease inhibitor (Mil-
liporeSigma) and 10% sodium orthovanadate phosphatase inhibitor (MilliporeSigma), re-
spectively. Arginase activity in lung digest cells was measured as previously described 
[42]. Briefly, enzyme was activated by addition of 10 mM MnCl2 at 55 °C for 10 min. Ar-
ginine (0.5 M) was added to samples and incubated at 37 °C overnight. Following incuba-
tion, the reaction was terminated by the addition of an acid solution containing H2SO4, 
H3PO4 and ddH20. Samples were then treated with 9% α-Isonitrosopropiophenone diluted 
in 100% EtOH for 45 min at 100 °C. Samples were allowed to sit in the dark for 10 min 
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prior to read out using a µQuant spectrophotometer (490 nm). Data was analyzed using 
KC Junior analysis software. 
2.10. Statistical Analysis  
Data were analyzed using Sigma Plot statistical software (Systat Software, Inc., San 
Jose, CA, USA). Two way analysis of variance (ANOVA) was used to determine differ-
ences between and within groups when appropriate. If assumptions of normality and/or 
equal variance were not met, each individual time point was analyzed using one way 
ANOVA, student’s t-test, or nonparametric equivalents Kruskall-Wallis or Mann–Whit-
ney U rank sum tests. If statistical differences were detected by ANOVA or the Kruskall-
Wallis test, post hoc tests were run to determine the differences between groups. Data 
were statistically different when the p value was less than 0.05. 
3. Results 
3.1. CD4 Lymphocytes Express IL-4 in Response P. murina  
Because T cells from neonates are known to have a biased Th2 response to antigens, 
we first asked whether P. murina infection in neonatal mice would result in an IL-4 re-
sponse in the lungs. We therefore utilized IL-4-eGFP reporter (4get) mice to determine if 
CD4+ T cells produce IL-4 in response to P. murina. We have previously reported that adult 
BALB/c mice cleared P. murina between 3 and 4 weeks post-infection while mice infected 
as neonates did not clear until about 6 weeks post-infection [9]. Transgenic 4get adults 
and neonates cleared P. murina with kinetics similar to that observed in wild type mice on 
B6D2F1, BALB/c and C57BL/6 backgrounds confirming that the transgene did not impact 
clearance mechanisms of the organism (Figures 1A, A1A and A2A). The proportion and 
the absolute number of activated CD4+ CD44hiCD62Llo cells that also expressed IL-4 
peaked in the BALF, lung digest, and draining lymph nodes (TBLN) of adults at day 11 
post-infection and in neonates at day 28 or later post-infection (Figure 1B–G). IL-4 expres-
sion was not observed in CD8+ T cells or B cells within the lungs or TBLN. The peak of IL-
13, IFNγ, and TNF levels in the BALF was at day 11 or earlier in adult mice infected with 
P. murina but not until day 28 post-infection in mice infected as pups (Figure A3A–C). 
These peaks corresponded with the peak of infection for both groups of mice.  




Figure 1. Activated CD4 lymphocytes from P. murina infected neonates and adults express IL-4. 4get 
pups (2-day-old) and adults (≥8 weeks) were infected with 5 × 105 P. murina organisms/g of body 
weight. At indicated days post infection, BALF, right lung lobes, and TBLN were collected from 4–
6 mice per group. (A) P. murina lung burden was determined microscopically. Cells from TBLN 
(B,C), lung digest (D,E), and BALF (F,G) were treated with PMA and ionomycin, stained with anti-
body against CD4, CD44 and CD62L, and analyzed by flow cytometry for IL-4-eGFP expression. 
CD4+ cells expressing high CD44 and low CD62L were considered to be activated. Data represent 
the mean ± SD and are representative of 2 independent experiments. * p ≤ 0.05, comparing P. murina 
infected 4get neonates to P. murina infected 4get adults. 
3.2. Cells of the Myeloid Lineage Express IL-4 in Response to P. murina  
It has been reported that macrophages can produce IL-4 in response to infection [43]. 
Following infection with P. murina, we observed up-regulation of IL-4 production by the 
myeloid populations within the BALF of neonatal but not adult mice (Figure 2A–C). Com-
pared to adults, the number of CD11c+CD11b- AMs that were IL-4+ within the BALF of P. 
murina-infected neonates was significantly increased at day 41 post-infection (Figure 2A). 
The number of CD11c+CD11b+ cells (activated AMs) that were IL-4+ within the BALF was 
significantly increased in neonates as compared to adults at day 28 post-infection and re-
mained elevated through clearance of P. murina (Figure 2B). Additionally, a significant 
increase in infiltrating CD11c-CD11b+ cells expressing IL-4 was observed in neonates at 
day 28 (Figure 2C). Arginase concentration in the lungs, known to be driven by Th2-like 
cytokines and produced by alternatively activated macrophages [44], peaked at day 11 
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post-infection in adult mice and at day 28 post-infection in neonatal mice corresponding 
to the peak in IL-4-producing cells in the lungs for both groups of mice (Figure 2D). To 
further characterize these IL-4-producing myeloid cell populations, cells in BALF col-
lected from P. murina-infected 4get adults and neonates were sorted based on IL-4 expres-
sion and high, intermediate, or low expression of CD11b and visualized by Diff-Quik stain 
and light microscopy (Figure 2E,F). The morphology of cells within these various popu-
lations was similar between adults and pups. Comparing cells at peak infection in adults 
(day 11) and neonates (day 28), CD11bmidIL-4+ and CD11bhiIL-4+ populations had morpho-
logical characteristics of both neutrophils and macrophages, whereas the CD11bloIL-4+ 
population was composed of cells with macrophage morphologic characteristics (Figure 
2F). Myeloid-derived suppressor cells (MDSCs) have similar morphologic characteristics 
as both neutrophils and macrophages and have been reported in the lungs of rats and 
mice with PCP [45]. The total number of myeloid cells producing IL-4 is significantly 
higher at later time points in P. murina infected pups as compared to adults, so it is possi-
ble that this cytokine contributes to alternative activation of macrophages and generation 
of MDSC during the immune response and resolution of infection. 
 
Figure 2. Myeloid cells from BALF of neonates and adults produce IL-4 in response to P. murina 
infection. 4get pups (2-day-old) and adults (≥8 weeks) were infected with 5 × 105 PC organisms/g of 
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body weight. At indicated days post infection, BALF was collected and processed from 4–6 mice 
per group as described in materials and methods for flow cytometry analysis (A–C) or sorting of 
IL-4 expressing cells (E,F). (A–C) BAL cells were stained with antibody against CD11c and CD11b 
and analyzed by flow cytometry. CD11c+CD11b- cells are considered to be resident AMs and 
CD11c+CD11b+ are considered to be activated macrophages. (D) Lung digest lysates were used to 
determine arginase activity within the lung. (E,F) BALF cells were stained with antibody against 
CD11b and sorted based on IL-4 expression and high, intermediate, or low expression of CD11b. 
Sorted cells were spun onto glass slides and analyzed microscopically based on morphologic char-
acteristics. Data represent the means±SD and are representative of 2 independent experiments. 
Mann–Whitney rank sum tests were used to compare data at each individual time point. * p ≤ 0.05, 
comparing P. murina infected 4get neonates to P. murina infected 4get adults. 
3.3. Arginase is Not Necessary in the Neonatal Immune Response to P. murina  
Elevated arginase activity has been shown to remove L-arginine from the environ-
ment resulting in down-regulation of the T cell receptor CD3ζ chain from T cells and is a 
marker of alternatively activated macrophages [46,47]. Th2 cytokines IL-4 and IL-13, and 
the immunoregulatory molecule TGFβ, which we have previously shown to be upregu-
lated in postnatal developing lungs infected with P. murina [18,23], have been demon-
strated to stimulate arginase activity in macrophages [48]. We found arginase activity in 
the lungs of adults to peak around day 14 post-infection and in neonatal mice between 
days 21 and 28 following infection with P. murina (Figures 2D, S1B and S2C). We did see 
a small earlier shift in the peak of arginase activity in the lungs of BALB/c pups compared 
to C57BL/6 pups and significantly reduced levels of IL-13 in the BALF of C57BL/6 pups 
(Figure A2C,D). The low IL-13 concentrations in C57BL/6 pups did not affect arginase 
activity which was similar to the BALB/c pups throughout infection. The concentrations 
of IL-4, IL-5, TNF, and IFNγ in the BALF of BALB/c pups were also higher, though not 
statistically different, than in C57BL/6 pups at day 27 post-infection (Figure A2E–G). These 
data may suggest that small local concentrations of IL-4 or IL-13 are sufficient for induc-
tion of arginase in AMs in pups. 
To determine if arginase activity has a role in clearance of infection and/or controlling 
T cell responses in neonates, we utilized neonatal mice on a C57BL/6 background with 
lysozyme-expressing myeloid cells deficient in arginase (Lyz-Arg−/−), and infected them 
with P. murina to observe the immune response and resolution of infection. Lyz-Arg−/− 
neonates cleared P. murina with similar kinetics as wild type C57BL/6 neonates (Figure 
3A). Arginase activity was significantly decreased within the lungs of Lyz-Arg−/− neonates 
as compared to wild type pups suggesting that myeloid cells produce the bulk of the ar-
ginase activity in the lungs during infection with P. murina (Figure 3B). Examination of 
macrophage numbers and markers of activation (CD11b expression) and alternative acti-
vation (Ym1 expression) did not yield consistent results comparing wild type and Lyz-
Arg−/− mice when examined by flow cytometry over two independent experiments (Figure 
3C,D). We did find that the absence of arginase in lung myeloid cells did not track with 
changes in myeloid cell surface markers in infant mice. Following P. murina infection, in-
filtration of activated CD4+ and CD8+ T cells into the lung parenchyma (Figure 3E,F) and 
BALF was higher in Lyz-Arg−/− neonates at day 30 post-infection compared to wild type 
pups. No differences in P. murina-specific IgG was seen between wild type and Lyz-Arg−/− 
mice. Overall, these data demonstrate that myeloid cell-derived arginase does not play a 
significant role in the resolution of P. murina infection in neonatal mice but may help sup-
press T cell proliferation during the clearance and recovery phase of infection.  




Figure 3. Lyz-Arg−/− neonates have similar immune responses to P. murina as wildtype neonates. 
Two-day-old Lyz-Arg−/− and C57BL/6 (wildtype) pups were infected with P. murina. At indicated 
days post infection, BALF and right lung lobes were collected from 4–6 mice per group. (A) P. 
murina lung burden was determined microscopically. (B) Lung digest lysates were used to deter-
mine arginase activity within the lung. (C) BALF cells obtained at day 21 post-infection were stained 
with antibody against CD11c, CD11b, and Ym1 and analyzed by flow cytometry. CD11c+CD11b+ are 
considered to be activated AMs. CD11c+CD11b+ cells ((C), dot plots) were examined for Ym1 expres-
sion ((C), histograms) and mean fluorescent intensity quantitated as shown in (D). (E,F) Lung digest 
cells were stained with antibodies against CD4, CD8, CD44 and CD62L. T cell populations express-
ing high CD44 and low CD62L were considered to be activated. Data represent the mean ± SD and 
are representative of 2 independent experiments. * p ≤ 0.05, comparing P. murina infected C57BL/6 
neonates to P. murina infected Lyz-Arg−/− neonates at the same time point. 
3.4. IL-4 Has a Modest Impact on Clearance of P. murina  
Expression of IL-4 was significantly increased in CD4+ T cells (Figure 1) and CD11b+ 
cells (Figure 2) during the neonatal immune response to P. murina. Therefore, we infected 
IL-4 deficient neonates (IL-4−/− on a C57Bl/6 background) to examine the impact of IL-4 on 
immunity to P. murina in infant mice. Overall, IL-4−/− pups had significantly reduced P. 
murina lung burden compared to wild type pups across all time points (main effect), 
though when we did post hoc statistical tests we found there were not statistically signif-
icant differences at any single time point (Figure 4A). The absolute numbers of activated 
CD4+ and CD8+ T cells in the lungs of infected wild type and IL-4−/− neonates were similar 
across most time points, though the peak of infiltration of CD4+ T cells around 4 weeks 
post-infection was consistently up to 2 fold greater in the lung digests of the IL-4−/− pups 
while the peak in activated CD8+ T cells was higher and earlier in wild type pups (Figure 
4C,D). These data indicate that IL-4 has a minor inhibitory effect on clearance of P. murina 
as well as on the peak number of activated CD4+ T cells in the lungs of infected pups.  




Figure 4. IL-4 dampens the CD4+ T cells response to P. murina in neonatal mice. Two-day old 
C57BL/6 and IL-4−/− pups were infected with P. murina organisms. At indicated days post infection, 
BALF and lungs were collected from 4-7 mice per group. (A) P. murina lung burden was determined 
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microscopically. (B) Arginase activity from lung digest lysates was determined as described in ma-
terials and methods. (C,D) Lung digest cells were stained with antibodies against CD4, CD8, CD44 
and CD62L. T cell populations expressing high CD44 and low CD62L were considered to be acti-
vated. (E–L) BALF cells were stained with antibody against CD11c, CD11b, and Ym1 and analyzed 
by flow cytometry. CD11c+CD11b- cells are considered to be resident AMs and CD11c+CD11b+ are 
considered to be activated macrophages. (H,L) show representative histograms of Ym1 expression 
in IL-4−/− (dashed line) or wildtype (solid line) pups at day 30 post-infection. The shaded histogram 
is an isotype control. The mean fluorescence intensity (MFI) of Ym1 is quantitated over time as 
shown in the line plots. Data represent the mean±SD and are representative of 2 independent exper-
iments. * p ≤ 0.05; +, p = 0.057 comparing P. murina infected C57BL/6 neonates to P. murina infected 
IL-4−/− neonates; ++, p < 0.05 for the main effect between groups, IL-4−/− pups and wildtype pups 
irrespective of time points; NS, not significant. 
We further examined if the absence of IL-4 affected macrophage activation in the ne-
onatal immune response to P. murina. Arginase activity within the lungs of IL-4−/− neonates 
was significantly decreased as compared to their wild type controls, demonstrating that 
in response to P. murina, IL-4 drives a significant proportion of arginase activity (Figure 
4B). The proportion of myeloid cells within the alveolar spaces of infected IL-4−/− neonates 
was different than in wild type pups, with a higher proportion of CD11c+CD11b− cells and 
fewer CD11c+CD11b+ cells (Figure 4E,I). The total number of these cell populations fol-
lowed similar trends (Figure 4F,J) and suggests that IL-4 dampens the transition of resi-
dent AMs (CD11c+CD11b−) to an activation state (CD11c+CD11b+) [23]. Since IL-4 is asso-
ciated with driving the transition of macrophages to an alternative activation phenotype, 
we examined Ym1 expression on CD11c+CD11b− AMs and found that the number of Ym1+ 
cells was similar between IL-4−/− and wild type pups however the MFI peaked at day 21 
post-infection in IL-4−/− pups compared to a peak at day 30 post-infection in wildtype pups 
(Figure 4G,H). Similarly, the MFI of Ym1 on CD11c+CD11b+ cells was significantly de-
creased as was the number of CD11c+CD11b+ cells expressing Ym1 at 30 days post-infec-
tion in P. murina infected IL-4−/− neonates (Figure 4K,L), consistent with Ym1 expression 
being partially driven by IL-4 in response to P. murina. These data indicate that in the 
neonatal immune response to P. murina, IL-4 drives arginase activity and to some extent 
Ym1 expression. Notably, we did not see any differences in mannose receptor (MR) ex-
pression on lung macrophages, another marker of alternative activation.  
In the absence of IL-4 we found that the levels of IFNγ in pup lungs were not different 
than in the lungs of P. murina-infected C57BL/6 wild type pups after day 21 post-infection 
(Figure 5A). We also failed to see IL-13 compensate for the lack of IL-4 and in fact IL-13 
was lower in the lungs of IL-4−/− pups at day 30 post-infection as compared to wild type 
pups (Figure 5B). Cytokines in the BALF had similar trends, though the levels were quite 
low, consistent with the low IL-13 concentrations found in the BALF of C57BL/6 pups as 
compared to BALB/c pups in supplemental Figure A2D. These data suggest that it is the 
balance of Th1 and Th2 cytokines, and not the absolute concentrations that control T cell 
and macrophage responses in pups.  
Because of the changes in T cells, macrophages, and a shift in balance of Th1 and Th2 
cytokines in IL-4−/− pups compared to wild type, we considered that P. murina-specific IgG 
could also be altered. However, we found that there was not a difference in the levels of 
P. murina-specific IgG in the sera of C57BL/6 versus IL-4−/− pups at any time point found 
(Figure 5C). The appearance of P. murina-specific IgG was late in the infection in pups, 
consistent with the delay in organism-specific IgG we have previously reported in the sera 
of pups compared to adults infected with P. murina [9].  




Figure 5. The absence of IL-4 does not significantly alter lung IFNγ levels or P. murina-specific serum 
IgG. Two-day-old C57BL/6 and IL-4−/− pups were infected with 5 × 105 P. murina organisms/g body 
weight. At indicated days post infection, lung homogenates were analyzed for (A) IFNγ and (B) IL-
13 levels in the left lobes by ELISA. (C) Serum P. murina-specific IgG was analyzed by ELISA. Data 
represent the mean ± SD of 4–7 mice and are representative of 2 experiments. * p < 0.05 compared to 
IL-4−/− pups at the same time point. 
3.5. IL-4Rα Deficiency Alters T Cell Activation in the Neonatal Immune Response to P. murina 
IL-4 had a modulatory effect on AMs in neonates infected with P. murina; however, 
we considered that IL-13 could also be contributing to the Th2-like environment in the 
neonatal lungs. Therefore, we utilized IL-4Rα−/− neonatal mice for our studies since IL-4 
and IL-13, though produced, are not able to function through the shared alpha chain of 
the IL-4 receptor. Notably, these mice were on a BALB/c background with a greater ten-
dency for Th2 responses but little difference in ability to clear infection than C57BL/6 pups 
as shown in Figure A2. Fifty percent of wild type mice had detectable P. murina within 
their lungs through day 41 post-infection while IL-4Rα−/− neonates completely cleared in-
fection by day 35 post-infection (Figure 6A). There was generally no difference in the ab-
solute number of activated CD4+CD44hiCD62Llo cells within the tracheobronchiolar lymph 
nodes (TBLN) of P. murina infected IL-4Rα−/− and wild type pups (Figure 6B). The number 
of CD8+CD44hiCD62Llo cells in the TBLN tended to be lower in the IL-4Rα−/− pup but the 
differences were small (Figure 6B). After day 20 post-infection both wild type and IL-
4Rα−/− neonates had an influx of activated (CD44hiCD62Llo) T cells into the lungs, however, 
IL-4Rα−/− neonates had significantly more activated CD4+ cells and CD8+ cells within the 
lungs as compared to wild type neonates at days 27 and 33 post-infection (Figure 6D,E). 
The number of activated CD4+ cells was lower in the alveolar spaces of the IL-4Rα−/− neo-
nates compared to the wild type pups (Figure 6F) while the number of activated CD8 + T 
cells was higher in the IL-4Rα−/− pups than in wild type pups (Figure 6G). Overall, it ap-
peared from these data that deficiency in IL-4Rα resulted in a more robust T cell response 
to P. murina infection in the lungs that corresponded to enhanced clearance of the organ-
isms. 




Figure 6. T cells are differentially activated in IL-4Rα−/− neonates infected with P. murina. Two-day 
old BALB/c and IL-4Rα−/− neonates were infected with 5 × 105 P. murina organisms/g body weight. 
At indicated days post infection, TBLN, lungs, and BALF were collected from 4–7 mice per group. 
(A) P. murina lung burden was determined microscopically. Cells from TBLN (B,C), lung digest 
(D,E), and BALF (F,G) were stained with antibody against CD4, CD8, CD44 and CD62L and ana-
lyzed by flow cytometry. T cell subsets expressing high CD44 and low CD62L were considered to 
be activated. Data represent the means ± SD and are representative of 2 independent experiments. * 
p ≤ 0.05; +, p = 0.067 comparing P. murina infected BALB/c neonates to P. murina infected IL-4Rα−/− 
neonates. ++, organisms burden was below limit of detection for 4 of 4 mice in the IL-4R−/− group 
and 1 of 4 mice in the BALB/c mice at day 35 and 4 of 4 and 2 of 4 for the IL-4R−/− and BALB/c mice, 
respectively, at day 41. 
3.6. Deficiency in IL-4Rα Results in a Reduction in Alternatively Activated Macrophages  
We next investigated whether IL-4Rα deficiency in P. murina infected neonates af-
fected activation of macrophages. Similar to IL-4−/− neonates (Figure 4B), IL-4Rα−/− neo-
nates had significantly less arginase activity within the lung following P. murina infection 
as compared to wild type neonates, confirming that the ability of macrophages to respond 
to IL-4 is essential in driving arginase activity during the immune response to infection 
(Figure 7A). Though there was no difference in the total number of CD11c+CD11b− cells 
(Figure 7B) in the alveolar spaces, IL-4Rα−/− neonates had significantly fewer 
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CD11c+CD11b+ cells (Figure 7C) in the alveoli at days 27 and 41 post-infection. The expres-
sion of Ym1 on CD11c+ cells that were either CD11b− or CD11b+ was decreased in IL-4Rα−/− 
pups compared to wildtype as seen by shifts on histograms at day 27 post-infection in 
Figure 7D,E. The MFI of Ym1 on CD11c+CD11b- cells (Figure 7F) and CD11c+CD11b+ cells 
(Figure 7G) was significantly lower in IL-4Rα−/− neonates at all days examined post-infec-
tion. These data demonstrate that during P. murina infection IL-4 and IL-13, signaling 
through IL-4Rα, drives lung macrophages towards an alternatively activated phenotype 
as evidenced by expression of Ym1 and production of arginase. 
 
Figure 7. P. murina infected IL-4Rα−/− neonates have a reduction in alternatively activated macro-
phages in the lungs. Two-day old BALB/c and IL-4Rα−/− neonates were infected with 5 × 105 P. murina 
organisms per gram body weight. At indicated days post infection, BALF and lung digest were 
collected from 4–7 mice per group. (A) Arginase activity from lung digest lysates was determined 
as described in materials and methods. (B–G) BALF cells were stained with antibody against CD11c, 
CD11b, and Ym1 and analyzed by flow cytometry. Resident AMs are CD11c+CD11b- and activated 
AMs are CD11c+CD11b+. Representative histograms from day 27 post-infection depicting Ym1 ex-
pression of gated macrophage populations from wild type (solid line) and IL-4Rα−/− (dashed line) 
mice and an isotype control (shaded) is shown (D,E). MFI of Ym1 over time is shown in panels F 
and G. Data represent the mean ± SD and are representative of 2 independent experiments. * p ≤ 0.05 
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comparing P. murina infected BALB/c neonates to P. murina infected IL-4Rα−/− neonates at the same 
time point. 
3.7. IL-4Rα Deficiency Affects the Cytokine Environment and Antibody Response to P. murina  
It is likely that IL-4Rα deficiency alters the cytokine milieu during the immune re-
sponse to P. murina in neonatal mice. We hypothesized that enhanced organism clearance, 
differential T cell activation, and a change in the phenotype of macrophages in P. murina 
infected IL-4Rα−/− neonates was associated with a decrease in Th2 cytokines and an in-
crease in Th1 cytokines in the lung lavage fluid (BALF). Wild type BALB/c pups had peak 
levels of IL-13, IL-5 and IL-4 in the BALF at day 27 post infection with P. murina (Figure 
8A–C). At this time point, P. murina infected IL-4Rα−/− neonates had significantly less IL-
13 and IL-5 within the BALF as compared to the wild type neonates (Figure 8A,B). There 
was no difference, however, in IL-4 in the BALF of BALB/c neonates and IL-4Rα−/− neo-
nates at any time point analyzed (Figure 8C). TNFα peaked in the BALF of both strains of 
mice at day 27 post-infection, however, this cytokine was observed at lower levels in the 
IL-4Rα−/− neonates (Figure 8D). IFNγ levels in the BALF were inversely related to IL-13 
and IL-5, as expected (Figure 8E). While IFNγ increased in the BALF of both strains of 
mice at day 27 post infection, it tended to be at higher levels in the IL-4Rα−/− neonates 
(Figure 8E). These data demonstrate that in IL-4Rα−/− neonates, there is a shift in the cyto-
kine milieu during the immune response to P. murina. 
Although we did not see a difference in P. murina-specific IgG in IL-4−/− pups com-
pared to C57BL/6 pups, we considered that the inability of cells to respond to both IL-4 
and IL-13 could have an effect on specific antibody production [49]. Indeed, there was a 
significant increase in P. murina-specific IgG in the sera of IL-4Rα−/− pups compared to 
wild type BALB/c pups (Figure 8F). This increase in specific antibody at days 34 and 41 
post-infection corresponded to reduced P. murina burden in the lungs of IL-4Rα−/− pups 
(Figure 6A). Together these data demonstrate that both IL-4 and IL-13 dampens the cellu-
lar and humoral immune response to P. murina in neonatal mice. 
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Figure 8. IL-4Rα−/− neonates infected with P. murina have a Th1-biased cytokine milieu. Two-day 
old BALB/c and IL-4Rα−/− neonates were infected with 5 × 105 P. murina organisms per gram body 
weight. At indicated days post infection, BALF was collected from 4–7 mice per group. (A) IL-13 in 
the BALF was determined by ELISA. (B–E) Levels of IL-5, IL-4, TNFα and IFNγ in the BALF were 
determined by Cytokine Bead Array. (F) Serum P. murina-specific IgG was determined by ELISA. 
Data represent the mean±SD and are representative of 2 independent experiments. * p ≤ 0.05 com-
paring P. murina infected BALB/c neonates to P. murina infected IL-4Rα−/− neonates at the same time 
point. 
3.8. IFNγ or IL-23 p19 Deficiency Alters the Immune Response but Not Ability to Clear P. 
murina Infection  
It is clear from the data shown that though the IL-4 bias effects the characteristics of 
the neonatal immune response to P. murina, IL-4 does not effect the ability of neonatal 
mice to clear infection. Both IFNγ and Il-17 have been implicated in clearance of P. murina 
in adult mice [32,50], possibly due to their ability to enhance phagocyte function. To de-
termine whether neonatal mice are able to clear P. murina infection in the absence of IFNγ 
or mature IL-17 response, neonates deficient in IFNγ or IL-23 (p19 KO) were examined. 
As shown in Figure 9A, there was no difference in P. murina lung burden between 
C57BL/6, IFNγ−/−, or IL-23 p19KO mice. In the absence of IFNγ or IL-23p19 the numbers 
of activated CD62LloCD44hi CD4+ cells in the alveolar spaces were elevated over the 
wildtype mice at day 31 post-infection (Figure 9B). In contrast, there were fewer activated 
CD8+ cells in the knockout mice at day 31 post-infection (Figure 9C). IFNγ concentrations 
in BALF were variable in the wildtype mice and quite low in the IL-23 p19KO mice (Figure 
9D). However, IL-13 levels in the lung lavages at day 20 post-infection were significantly 
elevated in the knockout mice over the wildtype controls consistent with a push toward a 
more intense Th2 response in the absence of Th1 and Th17 type responses (Figure 9E). 
Overall, deficiency in IFNγ or IL-23p19 resulted in shifts in lung cells and cytokine levels, 
but had no effect on clearance of P. murina.  
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Figure 9. Mice deficient in IFNγ or IL-23p19 clear P. murina with the same kinetics as wild type mice. 
Neonatal mice were infected with intranasal inoculations of 106 organisms and examined at days 20 
and 31 post inoculation for (A) lung organism burden determined microscopically, (B,C) = alveolar 
activated T cell numbers measured by flow cytometry, and (D,E) cytokine concentrations in the lung 
lavage fluid measured by ELISA. Data represents the mean ± SD of 4–8 mice (A–C) or individual 
mice with the mean shown (D,E). ** p < 0.05 knockout mice compared to C57BL/6 mice, * p < 0.05 
IFNϒ−/− mice compared to C57BL/6 mice. 
4. Discussion 
We have previously shown that the ability of neonatal mice to develop an immune 
response to P. murina is significantly delayed as compared to adult mice, resulting in de-
layed clearance of organisms from the lungs [9,10,18–23]. Here, we examined whether Th2 
cytokines, known to be abundant in infant mice and humans, have a role in the response 
to P. murina in mice infected as neonates. Because of the known functions of Th2 cytokines, 
we examined T cell, macrophage, and antibody responses to P. murina. We extend our 
previous findings to demonstrate that neonatal CD4+ T cells responding to P. murina pro-
duce IL-4 later during infection than in adult mice, which corresponds to the delayed in-
filtration of T cells into the lungs and so delayed clearance of infection. The spike in IL-4 
production by T cells and myeloid cells in the lungs occurred at the peak of infection and 
just prior to the clearance of the infection in pups. In the absence of IL-4 or IL-4Rα pups 
controlled P. murina infection slightly better than wild type pups and had reductions in 
alternatively activated macrophages at later time points as evidenced by reduced Ym-1 
expression and arginase production in the lungs. IL-4−/− and IL4Rα−/− pups had elevated 
numbers of activated CD4+ T cells in the alveolar spaces that corresponded to reduction 
in organism burden. Cytokine responses were tipped toward Th1 responses not because 
of elevated IFNγ but because of the absence of IL-4 or reduction in IL-13. There was a 
more striking reduction in P. murina infection in IL4Rα−/− pups at 5 and 6 weeks post-
infection than in the IL-4−/− pups which corresponded to significantly increased P. murina-
specfic serum IgG confirming that both IL-4 and IL-13 dampen the immune response to 
P. murina resulting in a prolonged clearance kinetics. 
The cytokine environment elicited by activated CD4+ T cells can drive macrophages 
towards various distinct phenotypes. Cytokines produced by Th1 (IFNγ), Th2 (IL-4, IL-
13, IL-33), Th17 (IL-17) and Treg (TGFβ) subsets of CD4+ T cells have been observed during 
the immune response to P. murina [28–34]. Consistent with previous work demonstrating 
a Th2 bias in neonatal immunity [11,27,51–53], we demonstrate a trend towards Th2 bi-
ased cytokine production during the neonatal immune response to P. murina. IL-4, IL-13, 
and IL-5, all produced during the immune response to P. murina in neonatal mice, are 
known to drive alternatively activated macrophages [48,54]. Because this phenotype is 
observed at peak infection and through clearance of organisms from the lung, it is possible 
that alternatively activated macrophages contribute to resolution of P. murina. Consistent 
with this, the β-glucan receptor Dectin-1 and MR have both been implicated in host de-
fense against PC [55,56] and are both upregulated in IL-4/IL-13 driven alternative activa-
tion of macrophages [57–59]. Moreover, Myers et al., reported that Th2-biased cytokines 
and alternatively activated macrophages led to reduced P. murina burden in C57BL/6 
background STAT4−/− adult mice compared to knockout mice on a BALB/c background 
[33]. Additionally, serum from HIV-infected individuals colonized with P. jirovecii con-
tained significantly lower Th2 cytokine concentrations than HIV-infected patients not col-
onized with the fungus suggesting that a Th2 cytokine environment is required for pro-
tection from colonization with PC [33].  
Th2 cytokines, IL-13 and IL-33, have been demonstrated to be produced at higher 
levels than IL-4 during the immune response to P. murina in adult mice [28]. Though we 
have yet to examine a role for IL-33 in the neonatal immune response to infection, we have 
detected both IL-13 and IL-5 within the BALF of P. murina infected BALB/c neonates. IL-
13 appears to play a redundant role to IL-4 in driving alternatively activated macrophages 
J. Fungi 2021, 7, 827 18 of 24 
 
 
in the neonatal immune response to P. murina. In the absence of IL-4 or IL-4Rα we found 
that clearance of organisms is somewhat improved which is counter to this notion that 
alternatively activated macrophages contribute to defense against P. murina and is more 
consistent with the idea that classically activated macrophages are the key to clearance as 
evidenced by the long-standing observation that TNF is a critical cytokine for clearance of 
P. murina [60–62].  
We demonstrated that in P. murina infected adults and neonates, CD4+ T cells and 
myeloid cells produce IL-4. The production of IL-4 corresponded with sustained alterna-
tive activation of AMs during the P. murina clearance phase in neonatal mice. Addition-
ally, IL-4-producing myeloid cells also had a phenotype reminiscent of MDSC with both 
a macrophage and neutrophil-like morphology [45]. MDSC were shown to be present in 
large numbers in adult rats and mice infected with PC [45]. The MDSC in PC-infected 
rodents expressed both iNOS and arginase and were able to suppress T cell proliferation 
[45]. Our observation of the appearance of these cells in neonatal lungs is consistent with 
the negative regulatory function of IL-4 and may represent a mechanism whereby IL-4 
suppresses clearance of P. murina.  
In the absence of the IL-4Rα we found a significant increase in the production of P. 
murina-specific IgG. This was somewhat surprising since Th2-biased responses are usu-
ally thought of as inducing humoral immunity. The elevated specific IgG occurred late 
during infection and corresponded with the time points at which P. murina lung burden 
was at the limit of detection in the IL-4Rα−/− pups but not in the wild type pups. Previous 
work has demonstrated that P. murina-specific IgG in IL-4−/− mice clears the organisms as 
or more efficiently than specific IgG in IFNγ−/− mice [36]. Deficiency in IL-4 did not signif-
icantly alter P. murina-specific IgG, though these mice were on a C57BL/6 background 
while the IL4Rα−/− mice were on a BALB/c background. While we did not see a difference 
in the clearance kinetics of P. murina on any of the 3 background strains of pups we exam-
ined, it may be that IL-13 contributed to the differences we found between IL-4−/− and IL-
4Rα−/− pups. In contrast, it has been reported that adult STAT4−/− mice on a C57BL/6 back-
ground, with a biased Th2 response, had higher P. murina-specific IgG2b and IgG2c titers 
than wildtype mice while STAT4−/− mice on a BALB/c background had no difference in 
specific antibody and had higher lung organism burden [33]. The differences in outcome 
between the Myers et al. study and our data could have to do with the differences in 
knockout models or alternatively, in the difference in the age of the mice. Indeed, in con-
trast to neonates, we showed that adult IL-4Rα−/− mice clear P. murina with the same ki-
netics as wild type control mice while LyzM-Arg−/− adults clear P. murina with a delayed 
kinetics compared to wild type control adults [63]. Consistent with this, Zhang et al., 
found that adult mice lacking IL-4Rα on macrophages were able to clear PC infection with 
the same kinetics as mice without IFNγR on macrophages concluding that neither M1 nor 
M2-biased macrophages are critical for host defense against PC [64]. These differences 
may have to do with intrinsic differences in neonatal macrophages.  
In summary, we have demonstrated that, upon mounting an immune response to P. 
murina, neonatal AMs are driven towards an alternatively activated phenotype, as meas-
ured by IL-4 expression in T cells and myeloid cells, IL-13 within the lung environment, 
and expression of Ym1 and arginase in resident and infiltrating macrophages. Interest-
ingly, MDSC were also found in the neonatal lungs. In IL-4Rα−/− neonates there was a shift 
from Th2 dominant cytokines towards Th1 cytokines and enhanced clearance of P. murina. 
In contrast, IFNγ−/− or IL-23p19KO pups on a C57BL/6 background, had a shift to a very 
high IL-13 cytokine response with no effect on clearance kinetics of P. murina. While cyto-
kines, such as IFNγ, are important in the resolution of P. murina, excess inflammation 
within developing lungs could cause irreparable damage. Based on these data, we hy-
pothesize that the presence of immunoregulatory cytokines, such as IL-4 and IL-13, and 
alternatively activated macrophages and MDSC during resolution of infection may play 
a protective role in the postnatal developing lung.  
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Appendix A 
 
Figure A1. P. murina-infected neonatal mice have significantly higher arginase activity in the lungs 
than infected adults. B6D2F1 mice were infected at 2 days (neonate) or 8 weeks (adults) of age with 
5 × 105 P. murina organisms/g of body weight. At indicated days post infection lung lobes were 
collected from 5–6 mice per group. (A) P. murina lung burden was determined by microscopic quan-
tification of organisms. (B) Lung digest lysates were used to determine arginase activity within the 
lung. Data represent the mean ± SEM from 5–6 mice per group and are representative of 2 inde-
pendent experiments. * p ≤ 0.05, comparing P. murina infected adults to infected neonates 




Figure A2. Strain background does not significantly alter clearance kinetics of P. murina in neonatal 
mice. Two-day-old BALB/c and C57BL/6 pups were infected with P. murina. At indicated days post 
infection, serum, BALF, and lung lobes were collected from 5–7 mice per group. (A) P. murina lung 
burden was determined microscopically. (B) Serum P. murina-specific IgG was determined by 
ELISA. (C) Arginase activity was determined from lung digest lysates as described in materials and 
methods. (D) IL-13 within the BALF was determined by ELISA. (E–H) IL-4, IL-5, TNF, and IFNγ 
concentration in the BALF were determined by Cytokine Bead Array and are shown as data from 
individual mice, horizontal line is the mean. * p ≤ 0.05, comparing P. murina infected BALB/c neo-
nates to P. murina infected C57BL/6 neonates. 




Figure A3. The peak of the cytokine response to P. murina is delayed in neonates compared to adults. 
4get mice were infected with P. murina at 2 days and >8 weeks of age. At the indicated time points, 
BALF was collected from 4–5 mice per group and assayed for IL-13 (A), IFN-γ (B), or TNF-α (C) 
concentrations by ELISA. Data represents the mean ± SD and are representative of two separate 
experiments. * p ≤ 0.05 comparing P. murina-infected pups and adults at the indicated time point. 
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